ClinicalKey AI vs OpenEvidence: In the UK, It's Not a Choice
This is a comparison with an awkward answer: if you are a UK clinician, there is nothing to compare.
OpenEvidence withdrew from the UK and EU on 28 April 2026. ClinicalKey AI did not. So the practical answer to "ClinicalKey AI or OpenEvidence?" in the UK is ClinicalKey AI, by default rather than by merit.
There is a second thing worth knowing, and it is stranger. Elsevier built ClinicalKey AI in partnership with OpenEvidence.
The shared history
In November 2023, Elsevier Health announced a partnership with OpenEvidence to develop ClinicalKey AI — a generative-AI clinical decision support tool built on Elsevier's medical content. The development drew on input from Cone Health, the University of New Mexico, and more than 30,000 US physicians.
Two things follow from that, and it is worth being precise about both.
The two products were never the same thing. They differ in content, in business model and now in geography. ClinicalKey AI answers from Elsevier's own licensed, copyright-cleared library. OpenEvidence built its own content partnerships and was free at the point of use.
And the partnership is no longer advertised. Elsevier's current ClinicalKey AI product pages make no mention of OpenEvidence. We do not know whether the technical relationship persists, and we would not assume it from a 2023 press release. What we can say is that the two tools have a common origin, and that only one of them still works here.
Side by side, as of July 2026
| ClinicalKey AI | OpenEvidence | |
|---|---|---|
| UK access | Available — individual and institutional | Withdrawn 28 April 2026 |
| Cost | Paid; 14-day free trial. Elsevier does not publish an individual list price | Was free at point of use |
| Content base | Elsevier's proprietary full-text, copyright-cleared library, refreshed daily — society guidelines (ACC, AACE, ACEP, CHEST, ESMO and others), high-impact journals including The Lancet, reference texts such as Braunwald's and Goldman-Cecil, plus drug information | Its own content partnerships |
| Citations | Inline, traceable to source | Referenced answers |
| Integration | EHR integration and API access for organisations | Web and app |
| What it does | Answers the clinical question you ask | Answered the clinical question you asked |
The last row is the one that matters most, and it is identical for both.
Why the comparison misses the point
Both of these are question-answering tools. You arrive with a question, and you leave with a referenced answer. That is genuinely useful — faster than a PubMed search, and better sourced than a search engine.
But a question-answering tool can only help with questions you already know to ask.
It will not tell you that a trial published three weeks ago has changed the first-line option in a condition you treat weekly. It will not mention the guideline update you missed while you were on nights. You have to already suspect that something has changed before any of these tools can confirm it.
That is not a flaw in the tools. It is a description of what they are for. Point-of-care Q&A and staying current with the literature are two different jobs, and buying one does not solve the other.
What we do instead
The Monday Clinical Brief is the other half of that pair.
Every Monday morning, we send you the new peer-reviewed papers published that week in the five highest-impact journals in your specialty. Plain-language summaries. Links to the originals. Nothing else.
We cover 31 specialties. £20 a year. No advertising, no sponsored content, no login, no app.
It is not a replacement for ClinicalKey AI, and we would not pitch it as one. If you want a referenced answer mid-clinic, use a query tool — ClinicalKey AI is the one UK clinicians can actually reach today. Use the digest for the reading, so that you know what to ask about in the first place.
The bottom line
For UK clinicians, ClinicalKey AI versus OpenEvidence resolves itself: one is available and one is not.
Choose ClinicalKey AI on its merits — the library is deep and the citations are traceable — but choose it knowing what it does. It answers questions. Something still has to tell you what changed this week.
See a free sample issue in your specialty — no sign-up required — or subscribe to The Monday Clinical Brief for £20 a year.
Related reading
- Looking for an OpenEvidence alternative in the UK? — the full picture of what UK clinicians can use now, with every alternative compared.
- Two AI tools UK doctors lost, one restricted — and what works in their place — the wider regulatory pattern behind the withdrawals.
- MCB vs UpToDate — the other established reference tool, and why its AI layer is still out of reach for UK individuals.
- Heidi Evidence is excellent — and in the UK it won't answer mid-consultation — a third tool, restricted rather than withdrawn.
Frequently Asked Questions
Can UK clinicians use OpenEvidence in 2026?
No. OpenEvidence withdrew from the UK and EU on 28 April 2026, citing regulatory uncertainty around AI in healthcare. It remains unavailable to UK clinicians regardless of credentials, and no re-entry has been announced.
Is ClinicalKey AI available in the UK?
Yes. ClinicalKey AI is available to UK clinicians both individually and through institutions, and Elsevier offers a 14-day free trial. Elsevier does not publish an individual list price publicly, so the cost depends on how you subscribe.
Is ClinicalKey AI the same as OpenEvidence?
No, though they share a history. Elsevier announced a partnership with OpenEvidence in November 2023 to develop ClinicalKey AI. They are separate products with different content, business models and availability: ClinicalKey AI is paid and answers from Elsevier's licensed, copyright-cleared library, while OpenEvidence was free to use and drew on its own content partnerships. Elsevier's current ClinicalKey AI product pages no longer reference OpenEvidence.
Which is better for UK clinicians, ClinicalKey AI or OpenEvidence?
For a UK clinician in 2026 the comparison is academic, because OpenEvidence cannot be accessed from the UK. Of the two, ClinicalKey AI is the one available. The more useful question is what each tool is for: both answer clinical questions you bring to them, and neither tells you what has just been published in your specialty.
Does ClinicalKey AI tell you about new research in your specialty?
Not in the way a digest does. ClinicalKey AI answers questions you ask it, drawing on a knowledge base Elsevier refreshes daily. It does not arrive each week with what is new in your field. Keeping current with the literature is a separate problem from point-of-care question answering — it is the one The Monday Clinical Brief covers, across the five highest-impact journals in each of 31 specialties.
Stay on top of the evidence
Weekly journal digests for 31 medical specialties. Structured summaries, every Monday.
Start your free trial →